H Gao1, S Hägg, P Sjögren, P C Lambert, E Ingelsson, R M van Dam. 1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory.
Abstract
AIMS: The relation between selenium status and risk of Type 2 diabetes is controversial. We aimed to evaluate associations of serum selenium, a marker of dietary selenium, with measures of glucose metabolism and risk of diabetes. METHODS: We used data from a population-based, longitudinal cohort of 1925 Swedish men who were 50 years old and did not have diabetes at baseline in the 1970s. At baseline, an intravenous glucose tolerance test was performed and, at a follow-up examination after 20 years, an oral glucose tolerance test and a hyperinsulinaemic euglycaemic clamp for the assessment of insulin sensitivity were conducted. RESULTS: At baseline, the mean (standard deviation) selenium concentration was 75.6 (14.3) μg/l. During 20 years of follow-up, 88 incident cases of diabetes occurred in 1024 participants with follow-up data. Baseline serum selenium levels were not associated with risk of diabetes (odds ratio 1.06; 95% CI 0.83-1.38). Higher selenium levels were associated with lower early insulin response (standardized β -0.08; 95% CI -0.14 to -0.03) at baseline after adjusting for potential confounders, but not with any other measures of β-cell function or insulin sensitivity at baseline or follow-up. The association with early insulin response was non-significant after taking multiple testing into account. CONCLUSIONS: Our results do not support a role of dietary selenium in the development of disturbances in glucose metabolism or diabetes in older individuals.
AIMS: The relation between selenium status and risk of Type 2 diabetes is controversial. We aimed to evaluate associations of serum selenium, a marker of dietary selenium, with measures of glucose metabolism and risk of diabetes. METHODS: We used data from a population-based, longitudinal cohort of 1925 Swedish men who were 50 years old and did not have diabetes at baseline in the 1970s. At baseline, an intravenous glucose tolerance test was performed and, at a follow-up examination after 20 years, an oral glucose tolerance test and a hyperinsulinaemic euglycaemic clamp for the assessment of insulin sensitivity were conducted. RESULTS: At baseline, the mean (standard deviation) selenium concentration was 75.6 (14.3) μg/l. During 20 years of follow-up, 88 incident cases of diabetes occurred in 1024 participants with follow-up data. Baseline serum selenium levels were not associated with risk of diabetes (odds ratio 1.06; 95% CI 0.83-1.38). Higher selenium levels were associated with lower early insulin response (standardized β -0.08; 95% CI -0.14 to -0.03) at baseline after adjusting for potential confounders, but not with any other measures of β-cell function or insulin sensitivity at baseline or follow-up. The association with early insulin response was non-significant after taking multiple testing into account. CONCLUSIONS: Our results do not support a role of dietary selenium in the development of disturbances in glucose metabolism or diabetes in older individuals.
Authors: Zhiyuan Cheng; Yuanyuan Li; Jamie L Young; Ning Cheng; Chenhui Yang; George D Papandonatos; Karl T Kelsey; John Pierce Wise; Kunchong Shi; Tongzhang Zheng; Simin Liu; Yana Bai Journal: Sci Total Environ Date: 2021-11-22 Impact factor: 7.963
Authors: Ewa Jablonska; Edyta Reszka; Jolanta Gromadzinska; Edyta Wieczorek; Magdalena B Krol; Sara Raimondi; Katarzyna Socha; Maria H Borawska; Wojciech Wasowicz Journal: Nutrients Date: 2016-12-13 Impact factor: 5.717
Authors: Zeinab Moshfeghy; Khadigeh Bashiri; Mohammad H Dabbaghmanesh; Marzieh Akbarzadeh; Nasrin Asadi; Mehrab Sayadi Journal: Int J Gen Med Date: 2020-02-20